Charles River Laboratories (CRL) has seen recent share price gains, up 15% over the past month, but is down 11.9% year-to-date. While Simply Wall St's...
Bullish
RBC Capital has initiated coverage on Charles River Laboratories International Inc. (NYSE:CRL) with an Outperform rating and a price target of $215. T...
Bullish
RBC Capital has initiated coverage on Charles River Laboratories International Inc. (NYSE:CRL) with an Outperform rating and a $215 price target. The ...